Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The Clinical Evidence: What Trials Actually Showed Evaluating AOD-9604 before-and-after outcomes requires separating animal data from human data
In Epithalon-treated fibroblast cultures, the increase in measurable telomerase activity (quantified by TRAP assay Telomeric Repeat Amplification Protocol) corresponds temporally with the increase in hTERT protein levels, suggesting that hTERT availability is indeed the rate-limiting step being addressed
If the injury is resolving well, most patients complete the full cycle and then take a two to four week break before evaluating whether a second cycle is needed
Realistic expectations acknowledge both the potential and limitations of peptide therapy
